Targeting inflammasome/IL-1 pathways for cancer immunotherapy.
Targeting inflammasome/IL-1 pathways for cancer immunotherapy.
复制标题
DOI:
10.1038/srep36107
复制
发表时间:
2016-10-27
影响因子:
4.6
通讯作者:
Li Z
中科院分区:
文献类型:
--
作者:
Guo B;Fu S;Zhang J;Liu B;Li Z
The inflammatory microenvironment has been shown to play important roles in various stages of tumor development including initiation, growth, and metastasis. The inflammasome is a critical innate immune pathway for the production of active IL-1β, a potent inflammatory cytokine. Although inflammasomes are essential for host defense against pathogens and contribute to autoimmune diseases, their role in tumor progression remains controversial. Here, our results demonstrate that the inflammasome and IL-1β pathway promoted tumor growth and metastasis in animal and human breast cancer models. We found that tumor progression was associated with the activation of inflammasome and elevated levels of IL-1β at primary and metastatic sites. Mice deficient for inflammasome components exhibited significantly reduced tumor growth and lung metastasis. Furthermore, inflammasome activation promoted the infiltration of myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) into tumor microenvironments. Importantly, blocking IL-1R with IL-1R antagonist (IL-Ra) inhibited tumor growth and metastasis accompanied by decreased myeloid cell accumulation. Our results suggest that targeting the inflammasome/IL-1 pathway in tumor microenvironments may provide a novel approach for the treatment of cancer.
登录
查看更多内容
影响因子:
29.7
作者:
Davis BK;Wen H;Ting JP
通讯作者:
Ting JP
影响因子:
7.8
作者:
Cassel SL;Joly S;Sutterwala FS
通讯作者:
Sutterwala FS
影响因子:
8.7
作者:
Broz P;Monack DM
通讯作者:
Monack DM
影响因子:
1.3
作者:
Gorbachev, Anton V.;Fairchild, Robert L.
通讯作者:
Fairchild, Robert L.
DOI:
10.1073/pnas.1016814108
发表时间:
2010-12-14
影响因子:
11.1
作者:
Hu, Bo;Elinav, Eran;Flavell, Richard A.
通讯作者:
Flavell, Richard A.